Full Transcript Introduction: Psychedelic Medicine and the Evidence Gap 0:01 [music] >> Welcome to the Trip Lab, kitchen table 0:05 conversations about integrative medicine and psychedelics. [music] 0:08 I'm your host and attending physician, Dr. Mariela Wood. 0:13 Welcome back, everyone. In today's episode, I want to talk about something 0:18 that I've been noticing in the psychedelic space and some questions 0:21 that it's been leading me to ask. And not just about psychedelics, but about 0:25 medicine more broadly. So, this field, psychedelic medicine, is moving fast. 0:30 Really fast. And at the same time, maybe actually not fast enough. Public 0:35 interest and use of psychedelics has far exceeded what medicine can currently 0:39 offer in a clinical setting. The data is growing rapidly, but our ability to 0:43 prescribe, recommend, or legally support psychedelic experiences, specifically in 0:48 a therapeutic way, is still pretty slim. Now, changes are happening. Right now, 0:53 outside of clinical trials, there really only two places in the US where people 0:57 can legally access psychedelic therapy. Oregon and Colorado. Everywhere else, 1:02 interest and use has far outpaced what medicine and policy can reasonably 1:07 support. And beyond that, these substances are still schedule one. And 1:11 just to say it out loud here, I don't think that they should remain classified 1:14 in that way as the new data emerges, but that is a conversation for a different 1:17 podcast. What is happening right now is this. 1:22 People are using these molecules. They're sourcing them in different ways. 1:26 They're microdosing on their own. They're doing full journeys on their 1:29 own. Or they're finding underground or ceremonial spaces to work with them. 1:34 And I want to be clear, I actually don't think this is inherently bad. I'm 1:38 definitely not in the camp that these medicines should only be available to 1:41 people who meet strict DSM criteria for a mental health diagnosis. When you 1:46 really take a step back and look at the DSM, it puts people into boxes. You miss 1:50 one criterion and you don't qualify. You meet one more and you do. And that's 1:55 just simply not how mental health works. But I'll leave that there for now. 1:58 Alongside people using these molecules, something else is happening. 2:03 A whole group of people are becoming {quote} experts. They're offering 2:07 education, microdosing protocols, training courses for facilitators, 2:12 clinicians, and guides. And here's the thing that we don't talk enough about. 2:17 Right now, there are no real regulating bodies for this emerging field. 2:22 So, people can complete a course, receive a certification, whether you're 2:25 a medical professional or not, and then suddenly you have authority in the 2:29 field. You're giving guidance about incredibly complex medicines. Now, 2:34 that's, again, not necessarily wrong, but it is worth slowing down and really
Microdosing, Protocols, and Who Counts as an Expert 2:38 looking at. Because a lot of the training and recommendations being 2:42 offered are based on extrapolated data, presumed mechanisms, theories about how 2:47 these molecules should work, rather than solid clinical evidence. And to be fair, 2:51 that evidence is emerging. We're getting more and more of it every day. But there 2:55 is at least one area where we actually don't have good data at all, and that's 2:59 microdosing. Most of the research to date suggested microdosing performs just 3:03 about as well as placebo. So, my obvious question is, where are all these 3:07 microdosing protocols coming from? And the answer is actually largely from 3:11 personal experience. So, experience that gets passed along slowly turns into 3:16 knowledge and then becomes something that other people experiment with, and 3:20 eventually more protocols are created. Which brings me to another question that 3:23 keeps coming up for me. Who are the experts here? 3:27 How do you become an expert in psychedelics? Is it taking a course? 3:31 Completing a training program? Just reading enough of the literature? 3:36 Personal experience or self-experimentation? 3:38 I think probably a mix of all that, but the boundaries are very blurry. So, in 3:43 this episode, I want to dive into all of this. 3:46 We'll also look at parallels in medicine throughout history, including 3:49 psychotherapy, where public interest actually outpaced the data and 3:53 experience formed before evidence fully caught up. I think therapy is a perfect 3:57 example about how this is not bad, it's actually a good thing. But I do want to 4:01 explore this a little bit more. We'll also come back to a question that 4:05 I touched on in a recent episode. How much evidence is enough evidence to 4:09 recommend something? If you want to check out that episode, it's titled Is 4:13 Modern Medicine Still Evidence-Based? Reclaiming Evidence, Restoring Clinical 4:17 Wisdom. Because I want to dive a little bit deeper into what I posed in that 4:20 episode and use psychedelics as a case study to help us understand medicine and 4:25 the world in general. So, let's zoom in on psychedelics, and then we'll zoom out 4:29 and think about the future of this space and what this could mean for how we can 4:33 shape medicine and the world. So, first I think it's worth briefly mentioning 4:37 what we do and do not know about psychedelics, because I think this is 4:40 where things get pretty interesting. I recently did a full episode on updates 4:44 in psychedelic science, if you really want all the nitty-gritty neuroscience, 4:47 which is in episode 25. But at a high level, we actually do know a lot more 4:51 than people sometimes realize. For full-dose psychedelic experiences, we 4:55 have a growing body of research showing pretty consistent patterns in the brain. 4:59 So, changes in network connectivity, modulation of the default mode network, 5:04 increased neural flexibility, and now emerging evidence that these experiences 5:08 also affect the body. So, inflammation, stress physiology, and even immune 5:13 signaling. And clinically, the data are generally promising, especially for 5:17 depression, anxiety, addiction, end-of-life distress, and PTSD. So, not 5:23 perfect data, not final answers, but enough rigorous findings to really take 5:27 this field seriously. But of course, we certainly do not know everything, which 5:31 means that not all psychedelic use is equally supported by the evidence. I 5:35 think microdosing is the clearest example of this. As I mentioned earlier, 5:40 when you actually look at the research we have so far, microdosing has not been 5:44 shown to outperform placebo. Across multiple studies, people do feel better, 5:49 but so do the people taking placebo. And I think that tells us something really 5:52 important. That expectation, meaning, narrative, and context are actually 5:57 playing a huge role. So, I personally think that this does 6:01 not mean microdosing is useless, but I do think we should be more honest about 6:06 what's driving the effects. So, despite the very little evidence 6:10 that we have that microdosing alone impacts outcomes, rather than just a 6:15 therapeutic experience of taking the microdose, there are very confident 6:19 microdosing protocols everywhere. We have specific schedules, doses, 6:24 claims about focus, creativity, mood, and productivity. 6:29 And again, it's coming from experience, extrapolation, and plausible-sounding 6:33 theories about how these molecules should work. There's a great paper that 6:36 I recently read. It's called The Illusion of Knowledge in the Emerging 6:39 Field of Psychedelic Research, and it talks a lot about this in a more 6:42 clinical way. The authors make the case that in fast-moving, high-excitement 6:46 fields like this, we often confuse compelling narratives with actual 6:50 understanding. We build clean explanations on top of very early data. 6:55 And we speak with a level of certainty that isn't quite justified yet. 6:59 Not because people are being dishonest, but because humans are really good at 7:02 filling in the gaps, especially when something feels meaningful. And this 7:06 paper is actually not anti-psychedelic at all. If anything, it's a call for 7:10 humility. It points out how easy it is in an emerging field to mistake 7:14 coherence for truth. To believe that because something makes 7:18 sense, it must be proven. And this is where things start to shift from science 7:22 into culture. Because once ideas start circulating through podcasts, courses, 7:26 trainings, protocols, they begin to take on a life of their own. They feel 7:30 established. They feel vetted. They feel safe.
Clinical Evidence, Uncertainty, and Integrative Medicine 7:34 Even when the evidence underneath them is still pretty thin. 7:38 And this is the moment that I think we're in right now. Not a moment of 7:41 fraud or bad actors, but a moment where structure starts to masquerade as 7:46 validation. And I want to talk about that next. So, this is the part where 7:49 things can get a little bit uncomfortable, and I want to be really 7:52 clear that I'm actually including myself in this questioning. Because once you 7:56 start noticing how fast ideas harden into protocols, the next obvious 8:00 question is, who exactly gets to be an expert in an emerging field like 8:05 psychedelic medicine? And I personally really had to examine this. I talk about 8:10 psychedelics a lot on this podcast. I talk about them in the clinic. 8:14 I do a lot of counseling around them, mostly harm reduction counseling, which 8:17 is what legally is allowed right now. And I have read a lot of the research 8:21 papers that have come out in this space. And I have a clinical background that 8:25 helps me translate research into the person actually sitting in front of me. 8:29 So, does all that make me an expert? Maybe, maybe not. What I haven't done, 8:33 and I'll be completely honest, is I have not completed a psychedelic 8:36 certification course. I really like the idea of doing one, but right now, it 8:41 just doesn't make sense for me yet. Not because I think these programs are 8:45 bad, but because many of them are taught by people essentially doing the same 8:48 thing that I'm doing. So, reading the literature, synthesizing it, and trying 8:52 to make it relevant to real humans. And because I do live and work in a modern 8:56 medicine setting where board certifications, licensure is extremely 9:00 important and really does give you credibility, and I just haven't found a 9:04 course that I think gives me that same level of credibility. Now, I actually do 9:07 think that there are some programs out there that look pretty credible, because 9:10 they are connected to academic institutions and are transparent about 9:14 what is evidence-based, what is experiential, and what is still 9:17 speculative. For example, there's programs associated with universities 9:21 like CIIS, training organizations like Fluence that are deeply embedded in 9:25 research and clinical translation. And of course, MAPS, particularly around 9:29 MDMA-assisted therapy, where there are very specific research-driven protocols 9:33 tied to FDA trials. So, what I think makes these ones more credible is not 9:37 that they're perfect, it's that they're closely tethered to data, ethics, and 9:41 clearly defined scopes of practice. But here's the big point in all of that. 9:45 There is no external regulating body that certifies psychedelic training 9:49 programs. No equivalent of medical school accreditation, residency 9:53 standards, fellowship requirements, board exams. And in medicine, those 9:57 structures exist precisely because we decided, collectively, that expertise 10:01 shouldn't be self-conferred. Now, again, I want to pause here and say something 10:05 else that I think is really important. I personally don't believe that you need 10:09 letters after your name to have an authority or expertise in a field. A 10:13 perfect example of this is patients. I actually want and highly encourage my 10:17 patients to become experts in their own bodies and in their own health 10:20 conditions, and I think they absolutely can be. They don't need to be an MD or a 10:25 DO to understand their lived experience in a way no clinician ever fully could. 10:29 And I think the same principle applies in the psychedelic space. There are 10:33 people without, quote unquote, formal medical credentials who really do have 10:36 deep insight, careful judgment, and a level of experiential knowledge that 10:41 genuinely does matter. So, that shouldn't be dismissed, and I'm 10:44 not dismissing that. But, what I do want to point out is that I do think it's 10:48 fair to say that rigorous clinical training does shape how someone 10:51 integrates new information. So, medical training doesn't just teach facts. It 10:55 trains pattern recognition, risk assessment, differential thinking, and 10:59 an appreciation for how complex and interdependent human physiology really 11:04 is. You simply can't compress the years of clinical immersion. And when I say 11:09 years, I'm talking 4 years of pre-med, 4 years of medical school, 4 to 8 years of 11:15 residency and fellowship. And during residency and fellowship, you're working 11:18 100-hour weeks. And I know it's legally 80-hour work weeks, but we all know that 11:23 that's [ __ ] But, essentially, you can't compress all 11:26 of those years of training into a short course. And of course, that's not what 11:29 the courses are intending to do. I'm just pointing out that having that 11:33 clinical background can help you understand physiology a little bit 11:36 better, and then take information about psychedelics and apply that to the 11:40 person sitting in front of you. So, I don't think you need to be a 11:44 physician to be an expert in psychedelics, but I do believe having a 11:47 deep clinical background can help when it comes to situating powerful 11:50 experiences and emerging data within the broader context of human health. 11:55 Especially when risk, vulnerability, and complexity are involved. And I actually 12:00 think that non-medical, non-doctor, however you want to say it, psychedelic 12:04 leaders can really partner to push this field forward. We have different 12:07 experience, different expertise, different backgrounds, and I think you 12:10 need all of that in psychedelic medicine. 12:13 So, my point with all of that is not about who gets to be an expert, who 12:16 doesn't. It's just about being honest about the 12:19 different kinds of expertise that exist, and about the responsibilities that come 12:23 with offering guidance in a space that's this powerful. What we need to 12:26 acknowledge is that psychedelic medicine does not have regulating bodies or 12:30 standard tools to accredit training programs. 12:33 And to be fair, the field is far too young to have this yet. Now, there are 12:37 actually some important exceptions to this that I think are worth naming here. 12:40 Ketamine is different. It's legal. It's already being used clinically. There are 12:46 research-based protocols, continuing education standards, and medical 12:50 oversight. MDMA is also different. It's not legal yet, but it has gone through 12:55 an unusually rigorous research pathway. MAPS has spent decades developing 13:00 structured, reproducible protocols to prepare clinicians for MDMA-assisted 13:04 therapy when and if it's approved. So, those ones are examples of expertise 13:09 being scaffolded by data. The classic psychedelics, so I'm talking 13:13 psilocybin, LSD, DMT, mescaline, aren't there yet. 13:18 And I think this is especially relevant with microdosing, because as we talked 13:22 about, the evidence just isn't there to show that it's better than placebo. 13:26 Again, I think that's still a notable finding, but just something to point 13:29 out. But, there are microdosing protocols everywhere. 13:32 And I think most modern microdosing protocols can be traced back to a mix of 13:35 the following. So, there's really popular book like The 13:38 Psychedelic Explorer's Guide. There's early anecdotal reports. 13:43 People are extrapolating full-dose psychedelic research and how that works. 13:47 And then people experiment themselves and then pass along what works, what 13:50 doesn't. And I think this is how human knowledge often develops at the edges. 13:55 Experience comes first, meaning follows, and then structure comes later. But, I 13:59 think what I'm uncomfortable with is when personal experience starts to sound
Lessons from Therapy, Biofeedback, and HRT 14:04 like a medical recommendation, especially in a field involving very 14:08 powerful psychoactive substances. So, I think we need to be really clear 14:12 about that, because if we don't, then confidence will fill the gap. And 14:16 confidence, especially when it's wrapped in certifications and protocols, can 14:20 look a lot like medical expertise, even if the evidence is just not there 14:25 yet. Which brings me to the next question, and one [clears throat] that 14:28 we spend a lot of time with in integrative medicine. 14:32 How much evidence is enough evidence to recommend something? 14:36 So, to backtrack a little bit, integrative medicine, which is what my 14:39 specialty is, is an actual medical specialty with a board certification 14:43 that blends modern conventional medicine with evidence-based therapies that were 14:47 once labeled, quote unquote, alternative. And it's certainly a lot 14:50 more than this. Integrative doesn't just mean blending alternative medicine with 14:54 modern medicine. It also involves integrating full patient care, 14:59 giving patients tools and power, working with other providers like 15:03 psychotherapists, pharmacologists, nutritionists, to best serve the 15:07 patients in front of us. But, going back to my point, in integrative medicine, we 15:11 live in a world of emerging data on therapies that have been used for 15:15 thousands of years, and also some new ones when we talk about more innovative 15:18 and longevity-based therapies. But, anyone in this field works daily to 15:23 try to parse out what works and what doesn't and what the evidence shows. 15:27 So, the question we often grapple with, or at least should grapple with, is when 15:32 is the evidence strong enough to bring something into clinical practice? In 15:35 some areas, like nutrition, we actually do have a lot of data. Not perfect data, 15:39 but enough to make thoughtful, evidence-informed recommendations. 15:44 In other areas, especially spaces like longevity, metabolic health, and 15:48 prevention, the ideas are still very emerging, 15:51 promising, biologically plausible, but not settled yet. 15:55 So, in integrative medicine, we've had to develop a different kind of clinical 15:59 reasoning, one that does not abandon evidence, but 16:03 also does not wait for perfect data before doing anything at all. 16:07 Because the reality is, people want to try these therapies despite the limited 16:10 data. Or because someone on Instagram has claimed the data where there isn't, 16:14 but a topic for another day. So, in integrative medicine, instead of only 16:18 asking, is there a large, randomized controlled trial, we ask more questions. 16:23 Like, is the proposed treatment mechanistically sound when we look at 16:27 human biology and physiology? Does it make sense based on what we know 16:30 about how the body actually works? Could it plausibly cause harm, 16:34 short-term or long-term? What is the risk-benefit ratio, 16:39 especially compared to doing nothing at all? 16:41 And importantly, is the patient interested? 16:44 Does this treatment align with their values, goals, and lived experience? 16:48 So, all those questions matter when you're practicing medicine in areas 16:51 where the evidence is still forming. And psychedelics deserve that same level 16:55 of scrutiny. And I actually do think that this 16:58 scrutiny is happening in psychedelic medicine. Many leaders in this field are 17:02 careful to talk about risks alongside of promise, 17:05 about screening, preparation, integration, and the reality that these 17:09 experiences can be destabilizing for some people. 17:13 But, because psychedelics specifically have gained so much traction, in a 17:16 beautiful way, they're actually inviting us to look more closely about how we 17:20 practice medicine in general, especially in all emerging fields. 17:24 How comfortable are we with uncertainty as clinicians? 17:28 How honest are we with patients about what we know versus what we're 17:32 extrapolating from the data? What else in medicine are doctors 17:36 recommending with such figure that we actually don't have enough evidence on? 17:40 And how do we balance curiosity and caution without becoming either reckless 17:46 or paralyzed? And if we really look at medicine, it 17:50 has actually never been practiced with perfect information. 17:53 Even if many doctors speak with such authority as though the information is 17:56 perfect. The truth is, we've always made recommendations under conditions of 18:00 uncertainty. The difference is whether we're willing to name that uncertainty, 18:05 or whether we hide behind it in protocols, credentials, and confident 18:09 language. And that, I think, is one of the deeper things psychedelics are 18:12 asking of all of medicine right now. But, psychedelics are actually not the 18:16 first to do this, and they certainly will not be the last. 18:20 Medicine has been here before, many times. In fact, we've been through 18:24 almost the exact same process with something we now consider one of the 18:27 most foundational treatments in mental health, and that's psychotherapy. Early 18:31 therapy was actually not mainstream medicine. It was not in guidelines. It 18:36 was not universally accepted. And for a long time, it was actually viewed as 18:40 fringe, unscientific, or even indulgent. So, Freud, psychoanalysis, talk therapy, 18:47 these ideas actually lived in the margins of medicine rather than inside 18:50 it. There was a lot of deep skepticism about whether talking could meaningfully 18:54 change biology, symptoms, or outcomes. So, over time, of course, that has 18:59 dramatically changed. As different therapeutic modalities developed, like 19:03 CBT, interpersonal therapy, trauma-informed approaches, the data 19:08 really started to accumulate. Slowly at first, unevenly, and not always cleanly, 19:14 but eventually, psychotherapy actually did move from the margins to the center. 19:18 Today, it's actually even hard to imagine a mental health guideline that 19:21 doesn't include therapy as a core recommendation, actually even before 19:25 medication. And that shift actually was not scientific, it was cultural. But, I 19:30 will say, even a few decades ago, therapy did carry a stigma. 19:34 When I was growing up, being in therapy often meant something was wrong with 19:37 you. It was not framed as proactive care or self-understanding. 19:41 It was framed as failure or pathology. That cultural narrative has changed 19:45 dramatically. Therapy is now widely understood as part of taking care of 19:49 your health, not evidence that you failed to do so. 19:52 We've also seen similar patterns in other areas of medicine. Think 19:56 biofeedback is another good example. So for years biofeedback and 20:00 neurofeedback lived on the edges used by a small group of clinicians often viewed 20:05 with skepticism and sometimes lumped in with things that were alternative or 20:09 quack medicine or not really scientific. And I will say the early evidence was 20:14 mixed. The mechanisms weren't always clear and protocols like psychedelics 20:19 varied widely. But again, over time biofeedback found its place and now it 20:24 actually is used in mainstream medical settings for conditions like migraines, 20:28 chronic pain, ADHD, pelvic floor dysfunction and anxiety. Often as an 20:33 adjunct not a replacement but still a legitimate tool nonetheless. Moving away
Indigenous Wisdom, Humility, and the Future of Medicine 20:38 from mental health, I think actually hormone replacement therapy is another 20:41 instructive example. Though I will say probably a more humbling and arguably 20:45 more complicated one. So for a long time HRT was widely prescribed based on a 20:49 strong physiological reasoning and early observational data. 20:53 Which made sense. Estrogen affects the bones, 20:56 cardiovascular health, cognition and mood and many women experienced dramatic 21:00 improvements in quality of life when they took hormone replacement therapy. 21:04 Then came the Women's Health Initiative which fundamentally shifted public and 21:08 medical perception of HRT. Framing it as dangerous, associated with 21:12 cancer and cardiovascular risk. And the response was swift and severe. 21:17 Prescriptions dropped, fear took completely over and almost an entire 21:21 generation of women was told that a therapy that had helped the woman before 21:25 them was now too risky to consider. So that was a major setback and a 21:29 disservice to a lot of women. Because now we revisited that data and 21:34 discovered flaws in the reasoning. The women that were studied in the Women's 21:37 Health Initiative were on average well past the onset of menopause. 21:42 And age alone significantly changes baseline cancer and cardiovascular risk. 21:47 Also the hormones used were largely synthetic not bioidentical and timing, 21:51 formulation and individual risk were not adequately parsed out. So those 21:55 important nuances were not meaningfully communicated to the public or even to 21:59 many clinicians. So the result was widespread fear around a therapy that 22:04 for many women is genuinely life-changing when used appropriately. 22:08 And now years later we've swung back to a more balanced understanding. HRT is no 22:13 longer abandoned. It also is not recommended to everyone. So our practice 22:17 has been refined. We talk about timing, formulation, individual risk assessment 22:23 and benefits alongside of risks. So that's what maturation looks like. 22:28 Not blind adoption, not wholesale rejection but learning and in this case 22:33 sometimes painfully how to hold complexity. So I think it's crucial that 22:38 we keep talking about things like this. It applies to psychedelics and other 22:42 aspects of medicine and life. So early adoption often does pave the way for 22:47 foundational treatments. But overconfident language can actually slow 22:51 progress especially when later data forces course corrections. 22:57 And psychedelics are moving through this arc right now. 23:00 We have early enthusiasm or I guess re-early enthusiasm because they were 23:04 used many many years ago. Rapid cultural uptake, growing but 23:08 incomplete data and a field learning in real time how to talk responsibly about 23:14 what it knows and what it does not. So seeing that pattern doesn't mean that we 23:17 should pull back in fear. It means acknowledging that the field is 23:21 still maturing and naming expertise in an emerging field requires a lot of 23:25 thought. So as we start to close I want to zoom out for a moment because I don't 23:30 think this episode is really just about psychedelics. 23:33 I think that psychedelics are acting as a mirror showing modern medicine 23:37 something about itself. These molecules are showing us how we 23:41 behave when the science is promising but incomplete. How we talk when experience 23:47 runs ahead of data. And how quickly authority forms when 23:51 structure, story and hope all come together at once. And there really is 23:56 something genuinely beautiful about this field. 23:59 These are molecules that come from the earth. 24:02 They've been in relationship with humans for a very long time 24:05 and many people, so researchers, therapists, guides, artists, indigenous 24:11 communities have devoted their lives to understanding them and long before 24:15 mainstream medicine was paying attention. So that alone deserves 24:19 respect. You don't need to be a physician to hold 24:22 deep wisdom about these medicines. You don't need an academic appointment 24:26 to have insight that matters especially when we talk about indigenous wisdom. 24:31 Indigenous communities have held, protected and transmitted understanding 24:35 of these medicines across generations and not as interventions 24:40 but as part of a broader worldview that integrates healing, meaning, community 24:44 and responsibility. And unfortunately that wisdom was 24:48 dismissed for a very long time. Now it is being rediscovered and respect 24:53 is being given. Sometimes imperfectly, sometimes clumsily but I think it does 24:57 matter deeply that we name where this kind of knowledge comes from. So 25:00 ultimately I don't want to draw hard lines about who can teach about this 25:04 plant wisdom and who can't. I just want to ask better questions. Where is this 25:09 information coming from? What kind of knowledge is this? Is it 25:13 data, inference, experience, indigenous wisdom or tradition? And how honestly 25:19 are we naming the uncertainty that still exists? To me real expertise especially 25:24 in emerging fields looks less like certainty and more like 25:28 diligence. Diligence is reading the data, 25:32 listening to lived experience, honoring indigenous wisdom without 25:37 appropriating or flattening it. And it's saying this is promising but 25:41 not settled. I think it also means resisting the temptation to sell 25:44 protocols as truth when the evidence is still forming. And this isn't unique to 25:49 psychedelics. We see the same pattern right now in in longevity medicine. 25:54 Longevity is exciting. It's sexy. There's fascinating biology, 25:58 real insights into metabolism, aging and resilience. But same as psychedelic 26:03 medicine there is no board certification in longevity medicine. 26:08 There's no standardized pathway that defines expertise and yet in parallel 26:13 there are very confident claims, supplements, protocols and strong 26:17 opinions everywhere. So this doesn't mean it's an 26:20 illegitimate field. It just means it also deserves the same careful scrutiny, 26:25 the same humility and the same honesty about what we know, what we're 26:28 extrapolating and what's still unknown. So I think maybe that's what 26:32 psychedelics are really asking of those who lead. 26:35 Not that we slow everything down. Not that we wait for quote unquote perfect 26:39 evidence. But that we learn to hold promise 26:43 without inflating certainty. Because the future of medicine does not 26:47 depend on how fast we adopt new tools. It depends on whether we can stay 26:51 honest, humble and human while we do so. And I think that's what makes this 26:57 moment in psychedelic medicine so exciting. 27:00 Not just the molecules themselves which are very exciting 27:04 but the invitation that they're offering us to practice medicine a little bit 27:08 more wisely. Psychedelics are teachers. Let's let 27:12 them teach. Thanks for listening to the Trip Lab. If 27:16 you liked this episode please subscribe and share so we can get the conversation 27:20 started about integrative medicine and psychedelics to destigmatize it and 27:24 fully explore what this could mean in the world. 27:27 >> [music]
Comments